Cargando…
An Experimental Generator for Production of High-Purity (212)Pb for Use in Radiopharmaceuticals
The feasibility, performance, and radiation safety of an experimental generator were evaluated to efficiently produce (212)Pb intended for radiopharmaceuticals. Methods: The generator consisted of a flask with a removable cap containing a source of (224)Ra or (228)Th absorbed on quartz wool. Gaseous...
Autores principales: | Li, Ruth Gong, Stenberg, Vilde Yuli, Larsen, Roy Hartvig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841245/ https://www.ncbi.nlm.nih.gov/pubmed/35798556 http://dx.doi.org/10.2967/jnumed.122.264009 |
Ejemplares similares
-
Dual targeting with (224)Ra/(212)Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
por: Juzeniene, Asta, et al.
Publicado: (2023) -
Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand (212)Pb-NG001
por: Stenberg, Vilde Yuli, et al.
Publicado: (2022) -
Evaluation of the PSMA-Binding Ligand (212)Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer
por: Stenberg, Vilde Yuli, et al.
Publicado: (2021) -
Targeted alpha therapy with the (224)Ra/(212)Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
por: Tornes, Anna Julie Kjøl, et al.
Publicado: (2022) -
In situ Generated (212)Pb-PSMA Ligand in a (224)Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-Positive Cells
por: Stenberg, Vilde Y., et al.
Publicado: (2020)